Globus Medical, Inc. (GMED) Q3 2026 earnings results
Globus Medical, Inc. (GMED) reported Q3 2026 results on Nov 5, 2026, 4:09:19 PM ET: adjusted EPS $1.23 vs. $1.20 expected (beat by 2.8%); revenue $763.72M vs. $792.46M expected (miss by 3.6%). Outlook: Full-year 2026 revenue guidance updated to $3.09 billion with non-GAAP fully diluted EPS guidance reaffirmed at $4.95 to $5.05.
| Metric | Reported | Analyst estimate | Result |
|---|---|---|---|
| EPS (adjusted, diluted) | $1.23 | $1.20 | Beat by 2.8% |
| Revenue | $763.72M | $792.46M | Miss by 3.6% |
Analyst estimate: the average forecast before the release.
Source
Figures from the SEC 8-K filing, released Nov 5, 2026, 4:09:19 PM ET. Nexqual published them 2 min 17 s after release. Each figure is confirmed by two independent extraction methods before it is published.
Year over year
Compared with the same quarter a year earlier (ended September 30, 2025, from the company's SEC filing): revenue fell 0.7% from $769.05M.
Stock reaction
The results came out after the market closed. GMED closed at $71.05 on November 6, 2026, down 12.8% from its $81.44 close on November 5, 2026 before the results. Latest: $74.96 as of 11:40 AM ET, −8.0% since the pre-release close.
Questions and answers
Did Globus Medical, Inc. beat earnings expectations?
Yes. Globus Medical, Inc. reported adjusted EPS of $1.23 against an average analyst estimate of $1.20 (beat by 2.8%), and revenue of $763.72M against $792.46M expected (miss by 3.6%).
What were Globus Medical, Inc.'s Q3 2026 earnings and revenue?
adjusted diluted EPS of $1.23 and revenue of $763.72M. Compared with the same quarter a year earlier (ended September 30, 2025, from the company's SEC filing): revenue fell 0.7% from $769.05M.
When did Globus Medical, Inc. report Q3 2026 earnings?
Nov 5, 2026, 4:09:19 PM ET, in an SEC 8-K filing (Item 2.02).
How did GMED stock react to the earnings?
The results came out after the market closed. GMED closed at $71.05 on November 6, 2026, down 12.8% from its $81.44 close on November 5, 2026 before the results. Latest: $74.96 as of 11:40 AM ET, −8.0% since the pre-release close.
What did Globus Medical, Inc. say about its outlook?
Full-year 2026 revenue guidance updated to $3.09 billion with non-GAAP fully diluted EPS guidance reaffirmed at $4.95 to $5.05.
More on GMED
GMED stock page: price, SEC financials, insider trades, superinvestor holders, analyst estimates and options. All results reported that day: earnings November 5, 2026.
Source: SEC EDGAR 8-K (Item 2.02), Nexqual Earnings Flash. Built November 10, 2026 at 16:40 UTC. Not investment advice.
Data source: Nexqual. Last updated: November 10, 2026 at 16:40 UTC. This page is informational and not investment advice.
For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt